Eccentric Cycling Vs. Standard Rehabilitation for Post-ICU Recovery in COVID-19 Survivors
Launched by UNIVERSIDAD NACIONAL ANDRES BELLO · Mar 24, 2025
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
Twenty patients (9 men, 11 women) between the ages of 30 and 60 years who had been hospitalized for COVID-19 in an ICU volunteered for this study. Participants were hospital-discharged at least 6 months before the start of the study and had not undergone rehabilitation after hospital discharge.
This study utilized a two-treatment crossover design. Each treatment was eight weeks in duration, with a two-week washout period. The order of treatments was randomized and counterbalanced. Twenty participants were recruited and completed this study. This sample was deemed sufficient as an a-priori ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants were hospital-discharged at least 6 months before the start of the study and had not undergone rehabilitation after hospital discharge.
- Exclusion Criteria:
- • Patients who did not pass the medical check-up before the study (patients with myocarditis and/or abnormal troponins or electrocardiograms from the last three months), oxygen-dependent patients, those with musculoskeletal injuries, bedridden patients, disoriented patients, or those with severe mental disabilities were excluded due to being unsafe to exercise.
About Universidad Nacional Andres Bello
The Universidad Nacional Andrés Bello (UNAB) is a distinguished higher education institution in Chile, recognized for its commitment to advancing research and innovation in the health sciences. With a strong emphasis on interdisciplinary collaboration, UNAB actively sponsors clinical trials aimed at enhancing medical knowledge and improving patient outcomes. The university leverages its extensive network of experts and state-of-the-art facilities to conduct rigorous research that addresses pressing healthcare challenges, ensuring adherence to ethical standards and regulatory compliance throughout the trial process. Through its initiatives, UNAB aims to contribute significantly to the global medical community and foster advancements in clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Santiago, , Chile
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported